Refining the definition of clinically important mineral and bone disorder in hemodialysis patients

BACKGROUND: It is important to identify an easily defined subset of patients at increased risk of adverse clinical outcomes associated with mineral and bone disorder (MBD) biomarkers (parathyroid hormone, calcium and phosphate). METHODS: Observational cohort study of 26 221 prevalent hemodialysis pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Danese, Mark D., Halperin, Marc, Lowe, Kimberly A., Bradbury, Brian D., Do, Thy P., Block, Geoffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
CLINICAL SCIENCE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513894/
https://www.ncbi.nlm.nih.gov/pubmed/25817224
http://dx.doi.org/10.1093/ndt/gfv034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513894/
https://www.ncbi.nlm.nih.gov/pubmed/25817224
http://dx.doi.org/10.1093/ndt/gfv034

Ejemplares similares